Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

Clinical trial NCT04147286 · RECRUITING

Trial details

NCT number: NCT04147286
Sponsor: University of Cape Town
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary

Start date: 2020-07-14
Primary completion: 2025-09-30
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.